Qube Research & Technologies (QRT)
OPRX icon

Qube Research & Technologies (QRT)’s OptimizeRx OPRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$760K Buy
120,943
+61,782
+104% +$574K ﹤0.01% 2610
2025
Q4 		$725K Buy
59,161
+40,578
+218% +$663K ﹤0.01% 2685
2025
Q3 		$381K Buy
+18,583
New +$295K ﹤0.01% 2784
2024
Q4 		– Sell
-20,430
Closed -$158K – 3729
2024
Q3 		$158K Buy
+20,430
New +$182K ﹤0.01% 2654
2024
Q2 		– Sell
-8,251
Closed -$100K – 4475
2024
Q1 		$100K Buy
+8,251
New +$120K ﹤0.01% 3295
2023
Q4 		– Sell
-1,146
Closed -$8.92K – 4629
2023
Q3 		$8.92K Buy
+1,146
New +$12.5K ﹤0.01% 3345
2023
Q2 		– Sell
-25,682
Closed -$376K – 2825
2023
Q1 		$376K Buy
+25,682
New +$430K ﹤0.01% 1667
2022
Q3 		– Sell
-46,912
Closed -$1.28M – 2866
2022
Q2 		$1.28M Buy
46,912
+14,056
+43% +$417K 0.01% 1004
2022
Q1 		$1.24M Buy
32,856
+26,097
+386% +$1.16M 0.01% 1057
2021
Q4 		$420K Buy
6,759
+3,343
+98% +$253K ﹤0.01% 1642
2021
Q3 		$292K Buy
+3,416
New +$214K ﹤0.01% 1500
2021
Q1 		– Sell
-6,895
Closed -$215K – 2275
2020
Q4 		$215K Buy
+6,895
New +$169K ﹤0.01% 1504

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OPRX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its OptimizeRx (OPRX) stake by 104% in Q1 2026, buying an estimated $574K and bringing the position to 120,943 shares worth $760K. The position accounts for ﹤0.01% of the portfolio, ranked #2610.

Qube Research & Technologies (QRT) first reported a position in OPRX in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.28M in Q2 2022. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 120,943 shares of OptimizeRx worth $760K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 61,782 OptimizeRx shares in Q1 2026, an estimated $574K.
  • OptimizeRx made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2610 holding.
  • Qube Research & Technologies (QRT) first reported a position in OptimizeRx in Q4 2020 and has held it in 12 quarters since.
  • Qube Research & Technologies (QRT)'s OptimizeRx position peaked at $1.28M in Q2 2022.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.